Samsung Electronics America Inc. has partnered with Heart Across America to host the Heart Across America cycling tour, aimed at increasing awareness on how to prevent heart disease and stroke.
Seventeen-year-old Ariana Smith recently became the first patient at the Children's Hospital of Michigan, and the first in Michigan, to benefit from a revolutionary 3-D printed heart model to treat a very large, complex aortic aneurysm.
If you enjoy this content, please share it with a colleague
The results of a blood test done immediately after heart surgery can be a meaningful indicator of postoperative stroke risk, a study by researchers at Wake Forest Baptist Medical Center has found.
Medtronic announced Japanese regulatory approval for the self-expanding transcatheter CoreValve system for patients with severe aortic stenosis (AS). Japanese regulatory authorities granted approval of the CoreValve system for transcatheter aortic valve implantation (TAVI) based on data from the CoreValve U.S. Pivotal Trials and the Medtronic CoreValve Japan Trial, which is the first study to evaluate a self-expandable transcatheter valve in the Japanese patient population.
SynCardia Systems Inc. has received U.S. Food and Drug Administration (FDA) approval to conduct an Investigational Device Exemption (IDE) clinical study on the effective use of its 50cc SynCardia temporary Total Artificial Heart.
Medtronic plc announced the initiation of the SPYRAL HTN Global Clinical Trial Program, a phased clinical program studying renal denervation in uncontrolled hypertension. This announcement follows investigational device exemption (IDE) approval by the U.S. Food and Drug Administration (FDA).
If you enjoy this content, please share it with a colleague